Welcome to CAMCEVI

A CONVENIENT PREFILLED, NO-MIX SYRINGE FOR GnRH AGONIST TREATMENT OF ADVANCED PROSTATE CANCER IN ADULTS

CAMCEVI® is the first sub-Q leuprolide that comes prefilled with no mixing. In an open-label, single-arm study of 137 adults who received 42 mg of CAMCEVI on Day 0 and Week 24, CAMCEVI offered consistent testosterone suppression to castrate levels, after the initial injection, from Week 4 to Week 48.1

See how simple syringe prep can be
PROVEN LEUPROLIDE EFFICACY

PROVEN
LEUPROLIDE EFFICACY

CAMCEVI offers proven leuprolide efficacy in a convenient prefilled,
no-mix syringe.1

See the results
SIMPLIFIED PREPARATION SIMPLIFIED PREPARATION

SIMPLIFIED
PREPARATION

CAMCEVI comes prefilled with no mixing required—simplifying syringe prep for you.1

Learn more about dosing

ADDITIONAL RESOURCES
AND SUPPORT

Access useful resources, information, and more for you and your patients.

See all resources

SIMPLE
ORDERING

Order CAMCEVI through your distribution and GPO partners.

Learn more

HAVE A QUESTION?

Let us simplify it for you.

CONNECT WITH A REPRESENTATIVE

    GET UPDATES

    Stay informed about
    CAMCEVI with regular updates,
    education, and more.

    *Required fields

    Reference:

    1. CAMCEVI. Prescribing information. Accord BioPharma; May 2021.